Vascular invasion affects survival in early hepatocellular carcinoma

被引:38
|
作者
Hsieh, Chen-Hsi [1 ,2 ,3 ]
Wei, Chang-Kuo [4 ]
Yin, Wen-Yao [4 ]
Chang, Chun-Ming [4 ]
Tsai, Shiang-Jiun [5 ]
Wang, Li-Ying [6 ,7 ]
Chiou, Wen-Yen [5 ]
Lee, Moon-Sing [5 ,8 ]
Lin, Hon-Yi [5 ,8 ]
Hung, Shih-Kai [5 ,8 ]
机构
[1] Far Eastern Mem Hosp, Dept Radiat Oncol, New Taipei 220, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan
[3] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan
[4] Buddhist Dalin Tzu Chi Hosp, Dept Gen Surg, Dalin 62247, Chiayi, Taiwan
[5] Buddhist Dalin Tzu Chi Hosp, Dept Radiat Oncol, Dalin 62247, Chiayi, Taiwan
[6] Natl Taiwan Univ Hosp, Coll Med, Sch & Grad Inst Phys Therapy, Taipei 100, Taiwan
[7] Natl Taiwan Univ Hosp, Coll Med, Phys Therapy Ctr, Taipei 100, Taiwan
[8] Tzu Chi Univ, Sch Med, Hualien 970, Taiwan
关键词
hepatocellular carcinoma; surgery; vascular invasion;
D O I
10.3892/mco.2014.420
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is an aggressive malignant tumor with a high mortality rate. The optimal therapeutic choice for early HCC is surgical resection. However, the rate of intrahepatic recurrence is high. The objective of this study was to evaluate the effect of various factors on the survival of patients with early HCC. Between January 1st, 2006 and December 31st, 2013, a total of 89 patients who underwent surgery for HCC were retrospectively enrolled. The analysis was conducted using the Student's t-test, Chi-square test, Kaplan-Meier method and Cox proportional hazard regression model to assess potential confounding and predictive variables. The 3-year overall survival (OS) rate was 71%. The 3-year OS rates in patients with and those without vascular invasion were 62.1 and 92.8%, respectively (P<0.003). Based on the multivariate analysis, postoperative pathological vascular invasion (hazard ratio =4.96; 95% confidence interval: 1.55-15.9) remained an independent predictor of adverse long-term outcome. Furthermore, vascular invasion was significantly associated with intrahepatic metastasis. These data emphasize the need for effective adjuvant therapy in selected high-risk patients with early HCC. Further studies are required to determine the optimal approach to further improving the prognosis of early HCC.
引用
收藏
页码:252 / 256
页数:5
相关论文
共 50 条
  • [31] Carbon-ion radiotherapy for hepatocellular carcinoma with vascular invasion
    Makishima, H.
    Yasuda, S.
    Kato, H.
    Kaneko, T.
    Sato, H.
    Chang, T.
    Kasuya, G.
    Yamada, S.
    Tsuji, H.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S570 - S571
  • [32] A novel microRNA signature predicts vascular invasion in hepatocellular carcinoma
    Han, Bing
    Zheng, Yujia
    Wang, Le
    Wang, Haixu
    Du, Jiaxin
    Ye, Fanglei
    Sun, Tongwen
    Zhang, Lianfeng
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) : 20859 - 20868
  • [33] MOLECULAR GENE SIGNATURE TO IDENTIFY VASCULAR INVASION IN HEPATOCELLULAR CARCINOMA
    Minguezi, Beatriz
    Hoshida, Yujin
    Villanueva, Augusto
    Toffanin, Sara
    Cabellos, Laia
    Newell, Philippa
    Roayaie, Sasan
    Schwartz, Myron E.
    Thung, Swan N.
    Mazzaferro, Vincenzo
    Bruix, Jordi
    Friedman, Scott L.
    Golub, Todd R.
    Llovet, Josep
    HEPATOLOGY, 2008, 48 (04) : 386A - 386A
  • [34] A nomogram to predict microvascular invasion in early hepatocellular carcinoma
    Li, Hongguang
    Li, Tao
    Hu, Jinhua
    Liu, Jun
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (03) : 652 - 657
  • [35] The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma
    Pote, Nicolas
    Cros, Jerome
    Laouirem, Samira
    Raffenne, Jerome
    Negrao, Magda
    Albuquerque, Miguel
    Bedossa, Pierre
    Godinho Ferreira, Miguel
    Ait Si Ali, Slimane
    Fior, Rita
    Paradis, Valerie
    LIVER INTERNATIONAL, 2020, 40 (04) : 956 - 967
  • [36] Gene-expression signature of vascular invasion in hepatocellular carcinoma
    Minguez, Beatriz
    Hoshida, Yujin
    Villanueva, Augusto
    Toffanin, Sara
    Cabellos, Laia
    Thung, Swan
    Mandeli, John
    Sia, Daniela
    April, Craig
    Fan, Jian-Bing
    Lachenmayer, Anja
    Savic, Radoslav
    Roayaie, Sasan
    Mazzaferro, Vincenzo
    Bruix, Jordi
    Schwartz, Myron
    Friedman, Scott L.
    Llovet, Josep M.
    JOURNAL OF HEPATOLOGY, 2011, 55 (06) : 1325 - 1331
  • [37] NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma
    Guo, Z-Y
    Zhu, Z-T
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (23) : 7238 - 7251
  • [38] Micro RNA Biomarker Candidates for Vascular Invasion in Hepatocellular Carcinoma
    Barry, C.
    Chuang, K.
    Dokus, M.
    Whitney-Miller, C.
    Orloff, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 535 - 535
  • [39] Upregulation of multidrug resistance-associated protein 4 in the early stage of vascular invasion of hepatocellular carcinoma
    Higuchi, K.
    Terada, T.
    Fukudo, M.
    Ogasawara, K.
    Katsura, T.
    Hatano, E.
    Ikai, I.
    Inui, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Could bile duct invasion be considered as the same as vascular invasion be in staging of hepatocellular carcinoma?
    Park, Yong Keun
    Kim, Bong-Wan
    Wang, Hee Jeong
    HEPATOLOGY, 2013, 58 : 1246A - 1246A